Literature DB >> 20548315

The in vitro spheroid melanoma cell culture assay: cues on tumor initiation?

Tobias Schatton1, Markus H Frank.   

Abstract

Cancer stem cells (CSCs) represent malignant subpopulations that initiate and maintain tumorigenic growth in hierarchically organized tumors via their considerable capacity for self-renewal and differentiation. CSCs have been identified in several human malignancies, including human malignant melanoma. Perego and colleagues' report in this issue indicates that CSCs capable of melanoma initiation in serial human-to-mouse xenotransplantation assays may be contained both among spheroid melanoma cell cultures (melanospheres) and among adherent melanoma cultures upon in vitro expansion. These results challenge the utility of the melanosphere assay as a surrogate tool for CSC identification in human melanomas and underline the importance of molecularly defined malignant melanoma initiating cells for CSC-focused diagnostic and therapeutic investigations.

Entities:  

Mesh:

Year:  2010        PMID: 20548315      PMCID: PMC2902551          DOI: 10.1038/jid.2010.135

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

Review 2.  Strengths and limitations of the neurosphere culture system.

Authors:  Josephine B Jensen; Malin Parmar
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

3.  Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells.

Authors:  Michela Perego; Monica Tortoreto; Gabrina Tragni; Luigi Mariani; Paola Deho; Antonino Carbone; Mario Santinami; Roberto Patuzzo; Pamela Della Mina; Antonello Villa; Graziella Pratesi; Giacomo Cossa; Paola Perego; Maria G Daidone; Malcolm R Alison; Giorgio Parmiani; Licia Rivoltini; Chiara Castelli
Journal:  J Invest Dermatol       Date:  2010-04-08       Impact factor: 8.551

4.  Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.

Authors:  Elena Monzani; Floriana Facchetti; Enrico Galmozzi; Elena Corsini; Anna Benetti; Chiara Cavazzin; Angela Gritti; Andrea Piccinini; Danilo Porro; Mario Santinami; Gloria Invernici; Eugenio Parati; Giulio Alessandri; Caterina A M La Porta
Journal:  Eur J Cancer       Date:  2007-02-22       Impact factor: 9.162

5.  A tumorigenic subpopulation with stem cell properties in melanomas.

Authors:  Dong Fang; Thiennga K Nguyen; Kim Leishear; Rena Finko; Angela N Kulp; Susan Hotz; Patricia A Van Belle; Xiaowei Xu; David E Elder; Meenhard Herlyn
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

Review 6.  The therapeutic promise of the cancer stem cell concept.

Authors:  Natasha Y Frank; Tobias Schatton; Markus H Frank
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

7.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

8.  MDR1 expression identifies human melanoma stem cells.

Authors:  Gilmor I Keshet; Itamar Goldstein; Orit Itzhaki; Karen Cesarkas; Liraz Shenhav; Arkadi Yakirevitch; Avraham J Treves; Jacob Schachter; Ninette Amariglio; Gideon Rechavi
Journal:  Biochem Biophys Res Commun       Date:  2008-02-13       Impact factor: 3.575

9.  Characterization of melanoma cells capable of propagating tumors from a single cell.

Authors:  Matthew A Held; David P Curley; David Dankort; Martin McMahon; Viswanathan Muthusamy; Marcus W Bosenberg
Journal:  Cancer Res       Date:  2010-01-01       Impact factor: 12.701

10.  Efficient tumour formation by single human melanoma cells.

Authors:  Elsa Quintana; Mark Shackleton; Michael S Sabel; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962

View more
  16 in total

Review 1.  Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?

Authors:  Nayoung Lee; Steven R Barthel; Tobias Schatton
Journal:  Lab Invest       Date:  2013-10-14       Impact factor: 5.662

2.  NME1 Drives Expansion of Melanoma Cells with Enhanced Tumor Growth and Metastatic Properties.

Authors:  Ying Wang; M Kathryn Leonard; Devin E Snyder; Matthew L Fisher; Richard L Eckert; David M Kaetzel
Journal:  Mol Cancer Res       Date:  2019-05-23       Impact factor: 5.852

3.  Melanoma spheroid formation involves laminin-associated vasculogenic mimicry.

Authors:  Allison R Larson; Chung-Wei Lee; Cecilia Lezcano; Qian Zhan; John Huang; Andrew H Fischer; George F Murphy
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

Review 4.  The role of stress and beta-adrenergic system in melanoma: current knowledge and possible therapeutic options.

Authors:  Roberta Colucci; Silvia Moretti
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-23       Impact factor: 4.553

5.  Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function.

Authors:  Kiran Ramgolam; Jessica Lauriol; Claude Lalou; Laura Lauden; Laurence Michel; Pierre de la Grange; Abdel-Majid Khatib; Fawzi Aoudjit; Dominique Charron; Catherine Alcaide-Loridan; Reem Al-Daccak
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

6.  Nestin depletion induces melanoma matrix metalloproteinases and invasion.

Authors:  Chung-Wei Lee; Qian Zhan; Cecilia Lezcano; Markus H Frank; John Huang; Allison R Larson; Jennifer Y Lin; Marilyn T Wan; Ping-I Lin; Jie Ma; Sonja Kleffel; Tobias Schatton; Christine G Lian; George F Murphy
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

7.  Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells.

Authors:  Yuval Peretz; Hong Wu; Shayan Patel; Alfonso Bellacosa; Richard A Katz
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

8.  Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation.

Authors:  Lucia Kucerova; Lucia Demkova; Svetlana Skolekova; Roman Bohovic; Miroslava Matuskova
Journal:  BMC Cancer       Date:  2016-05-12       Impact factor: 4.430

9.  CD133 Is Not Suitable Marker for Isolating Melanoma Stem Cells from D10 Cell Line.

Authors:  Motahareh Rajabi Fomeshi; Marzieh Ebrahimi; Seyed Javad Mowla; Javad Firouzi; Pardis Khosravani
Journal:  Cell J       Date:  2016-04-04       Impact factor: 2.479

10.  Remnant living cells that escape cell loss in late-stage tumors exhibit cancer stem cell-like characteristics.

Authors:  Y L Chen; S Y Wang; R S Liu; H E Wang; J C Chen; S H Chiou; C A Chang; L T Lin; D T W Tan; Y J Lee
Journal:  Cell Death Dis       Date:  2012-10-04       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.